Definition:R&D tax credit
🔬 R&D tax credit is a government incentive that reduces tax liability for companies investing in research and development activities, and within the insurance industry it has become an increasingly relevant tool as carriers, reinsurers, and insurtech firms invest heavily in technology innovation, actuarial model development, and new product design. Insurance companies often underestimate their eligibility for these credits because they do not think of themselves as "R&D companies," yet activities such as building proprietary catastrophe models, developing machine learning-based underwriting algorithms, creating new parametric insurance products, and engineering core platform technology frequently qualify under the R&D tax credit regimes maintained by many major economies.
💼 The mechanics of R&D tax credits vary by jurisdiction but generally follow a similar structure: qualifying expenditures — typically wages for technical staff, software development costs, and certain contracted research expenses — generate a credit or deduction that offsets corporate income tax. In the United States, the federal Section 41 credit allows companies to claim a percentage of qualified research expenses, with additional credits available at the state level. The United Kingdom offers a separate R&D relief scheme under which companies can claim enhanced deductions or, for loss-making entities, a cash credit — a feature that has been particularly valuable for early-stage insurtechs that have not yet reached profitability. France's Crédit d'Impôt Recherche (CIR) is among the most generous in Europe, while countries such as Australia, Canada, Singapore, and Ireland each maintain their own programs with distinct eligibility rules and benefit calculations. For insurance groups operating across borders, identifying and claiming credits in each jurisdiction requires coordination between tax, technology, and actuarial functions to properly document qualifying activities.
📊 The strategic value of R&D tax credits for the insurance sector goes beyond immediate tax savings. These incentives effectively reduce the after-tax cost of innovation, making it more financially viable for carriers to invest in areas like AI-driven claims automation, blockchain-based policy administration, telematics infrastructure, and advanced risk modeling capabilities. For insurtechs burning through venture capital to build scalable platforms, the ability to monetize R&D credits — either as cash refunds or as offsets against future tax liabilities — can materially extend runway and improve unit economics. Recent legislative changes in some jurisdictions, such as the U.S. requirement to capitalize and amortize research expenses under Section 174 starting in 2022, have complicated the calculus, but the credits themselves remain a significant and underutilized lever for insurance organizations committed to technology-led transformation.
Related concepts: